Background: This retrospective register study assessed overall survival (OS) and influential
factors on OS in Swedish renal cell carcinoma (RCC) patients. Methods: Using three merged …

Background This population-wide retrospective, non-interventional registry study assessed
changes in overall survival (OS) and factors influencing OS in Norwegian patients with renal …

Background This retrospective study investigated overall survival (OS) and factors
influencing OS in Swedish patients with metastatic renal cell carcinoma (mRCC) during the …

Introduction Because “real-life” patients often do not meet the strict eligibility criteria of
clinical trials, we assessed the trial eligibility of patients with advanced or metastatic renal …

BACKGROUND: Patients with end-stage renal disease (ESRD) are at risk of developing
renal tumours. OBJECTIVE: Compare clinical, pathologic, and outcome features of renal cell …

The incidence and mortality of renal cell carcinoma (RCC) in the Czech Republic are among
the highest in the world. Several targeted agents have been recently approved for the …

BACKGROUND: The increased finding of kidney 'incidentalomas' and more frequent surgery
in patients with renal cell cancer (RCC) metastases may have improved survival from the …

Background The aim of the RECCORD registry was to gather real-world UK data on the use
of targeted therapies in renal cell carcinoma (RCC) and assess clinical outcomes. Here …

BACKGROUND: Renal cell carcinoma (RCC) is the sixth leading cause of death in
developed countries. A third of all RCC patients are confronted with metastatic disease …

Introduction With the advent and availability of targeted therapy, the treatment of
advanced/metastatic renal cell carcinoma (RCC) underwent a drastic change in 2005. The …